Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor ConferenceGlobeNewsWire • 11/20/25
Clene Reports Third Quarter 2025 Financial Results and Recent Operating HighlightsGlobeNewsWire • 11/13/25
Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis PatientsGlobeNewsWire • 09/25/25
Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson's DiseaseGlobeNewsWire • 09/04/25
Clene to Present at the H.C. Wainwright 27th Annual Global Investment ConferenceGlobeNewsWire • 09/02/25
Clene Reports Second Quarter 2025 Financial Results and Recent Operating HighlightsGlobeNewsWire • 08/14/25
Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA MeetingsGlobeNewsWire • 06/30/25
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025Accesswire • 06/09/25
Clene Reports First Quarter 2025 Financial Results and Recent Operating HighlightsGlobeNewsWire • 05/07/25
Clene to Present at the Jones Healthcare and Technology Innovation ConferenceGlobeNewsWire • 04/01/25
Clene Reports Full Year 2024 Financial Results and Recent Operating HighlightsGlobeNewsWire • 03/24/25
Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11Accesswire • 02/27/25
Clene and APST Enter Into an Agreement to Support FDA's Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®'s Impact on NfL ReductionGlobeNewsWire • 02/25/25
FDA Provides Roadmap for Accelerated Approval Pathway Through Submission of Additional CNM-Au8® Biomarker Data in ALSGlobeNewsWire • 12/10/24
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq RulesGlobeNewsWire • 09/30/24
Clene Granted In-Person Meeting With FDA Senior Leadership to Discuss CNM-Au8 Biomarker and Related Clinical and Survival DataGlobeNewsWire • 09/16/24